Forensic Analysis · Technology / Software · as of Jul 10, 2026
Corvex, Inc. (MOVE)
A forensic read on Corvex, Inc. built from its complete SEC filings — financial-health screens, earnings quality, red flags and a price-aware rating. Reproducible math, not opinion.
F · Poor — capital at risk
Forensic grade
Distress
Financial health
-120.3
Altman Z-score
Clean
Earnings quality
3
Forensic signals
-2.9%
ROE
$521M
Market cap
Corvex, Inc. earns a F (Poor — capital at risk) forensic quality grade, and its Altman Z-score is -120.3, placing it in the Distress zone. 3 forensic signals were flagged in its latest SEC filings, led by return on invested capital.
What the filings flag
-102%Return on invested capital.Return on invested capital is -102% in the latest fiscal year and rising from -4119% — well below its ~10% cost of capital, so reinvested dollars may be destroying value, not building it.
306dInventory days.Days inventory outstanding moved from 248 to 306 FY2024→FY2025 (against cost of goods sold; inventory -14% vs -24% in cost of sales). Inventory is building a little faster than sales — watch for markdowns.
673% of revStock-based comp load.Stock-based compensation ran 673% of revenue in FY2025 — about $3.46 per diluted share. Meaningful — reported free cash flow flatters the economics, since SBC is a real cost paid in shares.
Key fundamentals
Latest Revenue433000.00
Revenue Growth YoY-57.3%
Net Margin-4222.9%
Free Cash Flow$-11.3M
Go deeper — free with an account
The forensic grade and screens above are free — no account needed. An account adds the full interactive deep-dive on Corvex, Inc.:
🔒The written investment read — what the numbers mean, in plain English
🔒Ask anything about MOVE's filings — AI Q&A across the 10-K, 10-Qs & 8-Ks
🔒Interactive valuation — reverse-DCF sliders, Monte Carlo & scenario stress
🔒Calibrated 12-month price forecast, with the math shown